&Partners’s Evotec EVO Stock Holding History

&Partners’s Portfolio EVO Stock Details EVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,818	Closed	-$45.4K	–	2140
2025 Q2	$45.4K	Buy	+10,818	New	+$42.4K	﹤0.01%	1953

Other funds holding EVO

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Pitcairn Conshohocken, Pennsylvania $1.27B AUM 23.64% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

&Partners's EVO Position: Q3 2025 in Review

&Partners sold out of Evotec (EVO) in Q3 2025, closing a stake of 10,818 shares — an estimated $45.4K sold.

&Partners first reported a position in EVO in Q2 2025 and held it in 1 quarter. The position peaked at $45.4K in Q2 2025. 37 funds tracked by Wall St. Rank hold EVO as of Q3 2025.

&Partners reported no remaining Evotec position as of Q3 2025 after selling out during the quarter.
&Partners sold 10,818 Evotec shares in Q3 2025, an estimated $45.4K.
&Partners first reported a position in Evotec in Q2 2025 and held it in 1 quarter.
&Partners's Evotec position peaked at $45.4K in Q2 2025.
37 funds tracked by Wall St. Rank held Evotec as of Q3 2025.

Based on &Partners's 13F filing for Q3 2025, filed 14 Nov 2025.